微生物检验对肺部曲霉菌感染的临床诊断价值  

Clinical Diagnostic Value of Microbiological Testing in Pulmonary Aspergillosis Infection

作　　者：何林林[1] 余广琼 刘航[1] HE Linlin;YU Guangqiong;LIU Hang(The Second People's Hospital of Deyang City,Deyang,Sichuan,China 618000)

机构地区：[1]四川省德阳市第二人民医院,四川德阳618000

出　　处：《中国药业》2023年第S02期159-161,共3页China Pharmaceuticals

摘　　要：目的探讨微生物检验在肺部曲霉菌感染的临床诊断价值。方法选取医院2021年3月至2023年2月接诊的肺部曲霉菌感染患者82例,患者均接受病理检验及微生物检验。结果2种检验方式的检验结果整体无显著差异。结论在肺部曲霉菌感染的诊断中,微生物检验结果与病理检验结果的整体差异较小,检验结果的准确率均相对较高。Objective To investigate the clinical diagnostic value of microbial testing in pulmonary aspergillosis infection.Methods A total of 82 patients with pulmonary aspergillosis admitted to the hospital from March 2021 to February 2023 were selected,and all patients underwent pathological and microbiological tests.Results There was no significant difference in the overall test results between the two testing methods.Conclusion In the diagnosis of pulmonary aspergillosis,the overall difference between microbial test results and pathological test results is small,and the accuracy of test results is relatively high.

关 键 词：肺部曲霉菌感染 微生物检验 病理检验 临床诊断价值 

分 类 号：R446.5[医药卫生—诊断学]